Net Cash Provided by (Used in) Operating Activities |
-92.5K |
USD |
-1484% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
-296K |
USD |
|
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-500K |
USD |
|
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
19.2M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-889K |
USD |
-15108% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
400K |
USD |
+168% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
231K |
USD |
+54.7% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
965K |
USD |
+130% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Interest Expense |
126K |
USD |
|
Q3 2022 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |